Stocktoria
Glass House Brands Inc. GLASF
OTC · OOTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2021-07-26
Glass House Brands Inc. financials (annual, from 10-K)
Bars are annual figures from 2021 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $182.0M | $200.9M | $160.8M | $90.9M | $69.4M |
| Gross profit | $77.0M | $97.4M | $81.0M | $20.7M | $16.0M |
| Operating income | -$16.5M | $5.7M | -$49.5M | -$56.4M | -$35.1M |
| Interest expense | — | — | $9.8M | $7.6M | $2.7M |
| Income tax | $11.9M | $10.5M | $9.9M | -$4.4M | $3.3M |
| Net income | -$29.7M | $519,000 | -$98.3M | -$32.9M | -$44.2M |
| EPS (diluted) | $-0.55 | $-0.21 | $-1.62 | $-0.83 | $-1.14 |
| Operating cash flow | $11.4M | $28.4M | $23.2M | -$40.8M | -$20.3M |
| Free cash flow | -$15.7M | $18.1M | $10.9M | -$68.6M | -$128.8M |
| Inventory | $26.2M | $14.3M | $8.8M | $11.0M | $6.6M |
| Total assets | $318.6M | $310.5M | $303.8M | $350.6M | $288.1M |
| Total liabilities | $144.0M | $146.4M | $158.5M | $129.5M | $107.2M |
| Shareholders' equity | $73.9M | $116.2M | $89.8M | $168.9M | $181.1M |
Growth · year-over-year · Revenue CAGR 27.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue growth | -9.4% | +24.9% | +77.0% | +30.9% | — |
| Net income growth | -5814.6% | — | — | — | — |
| Free cash flow growth | -186.9% | +65.8% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001848731 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.